China’s Pharma Licensing Deals Top $138.8 Billion, With $150.9 Billion in Sight This Year
15s
What happened
China’s pharmaceutical licensing agreements have reached $138.8 billion in total value, with projections indicating the figure could climb to $150.9 billion by year-end.